Global Dystrophin Supply, Demand and Key Producers, 2026-2032
The global Dystrophin market size is expected to reach $ 3154 million by 2032, rising at a market growth of 8.3% CAGR during the forecast period (2026-2032).
Dystrophin is an ultra-large structural protein encoded by the corresponding human gene and is mainly located on the inner side of the membrane of skeletal and cardiac muscle cells. The natural full-length muscle isoform is approximately 427 kDa and has a rod-like, multi-domain architecture composed of an N-terminal actin-binding domain, a central repeat rod domain, a cysteine-rich domain, and a C-terminal region. Together with the dystrophin-associated glycoprotein complex, it links the cytoskeleton to the extracellular matrix and helps stabilize the muscle membrane during contraction-induced mechanical stress.
At the industry level, Dystrophin does not refer to a single conventional chemical commodity. It represents a group of products designed to restore, replace, induce, or quantitatively detect this protein, including exon-skipping oligonucleotide drugs, micro- or mini-Dystrophin gene therapy vectors, stop-codon readthrough drugs, recombinant protein fragments, antibodies, and assay kits. Commercial presentations vary by dosage form or product format, including clear colorless injectable solutions, lyophilized powders, buffered protein or antibody solutions, pre-coated microplates, and matched reagent components. Major applications include treatment of Duchenne and Becker muscular dystrophy, therapeutic monitoring, drug screening, animal model validation, and basic research in muscle disease biology.
Dystrophin-related products have strong growth opportunities driven by rare-disease precision medicine, broader genetic testing, better patient stratification, and continuing payer interest in disease-modifying therapies. Exon-skipping drugs have already created a commercial foundation, while micro-Dystrophin gene therapy remains an important long-term direction despite a recent safety reassessment. Newer antibody-oligonucleotide conjugates, optimized chemistries, and lower-dose vector approaches are intended to improve muscle delivery, make therapeutic response more consistent, and expand the treatable patient base.
The key market challenges are clinical benefit validation, long-term safety, treatment cost, and regulatory uncertainty. Some currently marketed products rely on surrogate endpoints under accelerated approval pathways, so confirmatory trial results will strongly influence renewal, reimbursement, and prescriber confidence. Gene therapy products face liver toxicity, immune response, dose constraints, limited redosing potential, and manufacturing scale-up risks. Oligonucleotide products face chronic treatment burden, variable muscle uptake, and fragmented patient populations defined by specific exon-skipping eligibility.
Downstream demand is expected to move from single-mutation product use toward stratified and combined disease management. The diagnostic side will rely more heavily on genetic sequencing, Dystrophin expression testing, and quantitative muscle-function assessment. Treatment adoption will first concentrate in ambulatory children, early-diagnosed patients, and genetically eligible exon-skipping groups. Hospitals, rare-disease centers, clinical-trial networks, and pharmaceutical R&D teams will continue to require assay kits, reference proteins, antibodies, and animal-model validation tools. Although the research-reagent segment is much smaller than the therapeutic segment, it should remain relatively stable because it is supported by a continuing drug-development pipeline.
This report studies the global Dystrophin production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Dystrophin and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Dystrophin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Dystrophin total production and demand, 2021-2032, (K Dose)
Global Dystrophin total production value, 2021-2032, (USD Million)
Global Dystrophin production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Dystrophin consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Dystrophin domestic production, consumption, key domestic manufacturers and share
Global Dystrophin production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Dystrophin production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Dystrophin production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Dystrophin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sarepta Therapeutics, Roche, Nippon Shinyaku, PTC Therapeutics, REGENXBIO, Solid Biosciences, Dyne Therapeutics, Avidity Biosciences, Wave Life Sciences, Entrada Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Dystrophin market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (USD/Pcs) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Dystrophin Market, By Region:
1. How big is the global Dystrophin market?
2. What is the demand of the global Dystrophin market?
3. What is the year over year growth of the global Dystrophin market?
4. What is the production and production value of the global Dystrophin market?
5. Who are the key producers in the global Dystrophin market?
6. What are the growth factors driving the market demand?
Dystrophin is an ultra-large structural protein encoded by the corresponding human gene and is mainly located on the inner side of the membrane of skeletal and cardiac muscle cells. The natural full-length muscle isoform is approximately 427 kDa and has a rod-like, multi-domain architecture composed of an N-terminal actin-binding domain, a central repeat rod domain, a cysteine-rich domain, and a C-terminal region. Together with the dystrophin-associated glycoprotein complex, it links the cytoskeleton to the extracellular matrix and helps stabilize the muscle membrane during contraction-induced mechanical stress.
At the industry level, Dystrophin does not refer to a single conventional chemical commodity. It represents a group of products designed to restore, replace, induce, or quantitatively detect this protein, including exon-skipping oligonucleotide drugs, micro- or mini-Dystrophin gene therapy vectors, stop-codon readthrough drugs, recombinant protein fragments, antibodies, and assay kits. Commercial presentations vary by dosage form or product format, including clear colorless injectable solutions, lyophilized powders, buffered protein or antibody solutions, pre-coated microplates, and matched reagent components. Major applications include treatment of Duchenne and Becker muscular dystrophy, therapeutic monitoring, drug screening, animal model validation, and basic research in muscle disease biology.
Dystrophin-related products have strong growth opportunities driven by rare-disease precision medicine, broader genetic testing, better patient stratification, and continuing payer interest in disease-modifying therapies. Exon-skipping drugs have already created a commercial foundation, while micro-Dystrophin gene therapy remains an important long-term direction despite a recent safety reassessment. Newer antibody-oligonucleotide conjugates, optimized chemistries, and lower-dose vector approaches are intended to improve muscle delivery, make therapeutic response more consistent, and expand the treatable patient base.
The key market challenges are clinical benefit validation, long-term safety, treatment cost, and regulatory uncertainty. Some currently marketed products rely on surrogate endpoints under accelerated approval pathways, so confirmatory trial results will strongly influence renewal, reimbursement, and prescriber confidence. Gene therapy products face liver toxicity, immune response, dose constraints, limited redosing potential, and manufacturing scale-up risks. Oligonucleotide products face chronic treatment burden, variable muscle uptake, and fragmented patient populations defined by specific exon-skipping eligibility.
Downstream demand is expected to move from single-mutation product use toward stratified and combined disease management. The diagnostic side will rely more heavily on genetic sequencing, Dystrophin expression testing, and quantitative muscle-function assessment. Treatment adoption will first concentrate in ambulatory children, early-diagnosed patients, and genetically eligible exon-skipping groups. Hospitals, rare-disease centers, clinical-trial networks, and pharmaceutical R&D teams will continue to require assay kits, reference proteins, antibodies, and animal-model validation tools. Although the research-reagent segment is much smaller than the therapeutic segment, it should remain relatively stable because it is supported by a continuing drug-development pipeline.
This report studies the global Dystrophin production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Dystrophin and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Dystrophin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Dystrophin total production and demand, 2021-2032, (K Dose)
Global Dystrophin total production value, 2021-2032, (USD Million)
Global Dystrophin production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Dystrophin consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Dystrophin domestic production, consumption, key domestic manufacturers and share
Global Dystrophin production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Dystrophin production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Dystrophin production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Dystrophin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sarepta Therapeutics, Roche, Nippon Shinyaku, PTC Therapeutics, REGENXBIO, Solid Biosciences, Dyne Therapeutics, Avidity Biosciences, Wave Life Sciences, Entrada Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Dystrophin market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (USD/Pcs) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Dystrophin Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- DS-5141
- Biostrophin
- BMBD-001
- NS-065
- Others
- Exon-skipping Therapy
- Gene Therapy
- Stop-codon Readthrough Therapy
- Others
- Therapeutic Drugs and Vectors
- Antibodies and Assay Kits
- Recombinant Proteins and Protein Fragments
- Others
- Genetic Disorders
- Musculoskeletal Disorders
- Others
- Sarepta Therapeutics
- Roche
- Nippon Shinyaku
- PTC Therapeutics
- REGENXBIO
- Solid Biosciences
- Dyne Therapeutics
- Avidity Biosciences
- Wave Life Sciences
- Entrada Therapeutics
- Genethon
- Code Biotherapeutics
- Thermo Fisher Scientific
- Abcam
- Merck
- Bio-Techne
- Proteintech
- OriGene
- Cell Signaling Technology
- Santa Cruz Biotechnology
- Atlas Antibodies
- Leica Biosystems
- Creative BioMart
- MyBioSource
- NSJ Bioreagents
- Abbexa
- Abnova
- Boster Biological Technology
- Cloud-Clone
- FineTest
- CUSABIO
- Assay Genie
- Bioss Antibodies
- XpressBio
- BioGenex
- United States Biological
1. How big is the global Dystrophin market?
2. What is the demand of the global Dystrophin market?
3. What is the year over year growth of the global Dystrophin market?
4. What is the production and production value of the global Dystrophin market?
5. Who are the key producers in the global Dystrophin market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Dystrophin Introduction
1.2 World Dystrophin Supply & Forecast
1.2.1 World Dystrophin Production Value (2021 & 2025 & 2032)
1.2.2 World Dystrophin Production (2021-2032)
1.2.3 World Dystrophin Pricing Trends (2021-2032)
1.3 World Dystrophin Production by Region (Based on Production Site)
1.3.1 World Dystrophin Production Value by Region (2021-2032)
1.3.2 World Dystrophin Production by Region (2021-2032)
1.3.3 World Dystrophin Average Price by Region (2021-2032)
1.3.4 North America Dystrophin Production (2021-2032)
1.3.5 Europe Dystrophin Production (2021-2032)
1.3.6 China Dystrophin Production (2021-2032)
1.3.7 Japan Dystrophin Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Dystrophin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Dystrophin Major Market Trends
2 DEMAND SUMMARY
2.1 World Dystrophin Demand (2021-2032)
2.2 World Dystrophin Consumption by Region
2.2.1 World Dystrophin Consumption by Region (2021-2026)
2.2.2 World Dystrophin Consumption Forecast by Region (2027-2032)
2.3 United States Dystrophin Consumption (2021-2032)
2.4 China Dystrophin Consumption (2021-2032)
2.5 Europe Dystrophin Consumption (2021-2032)
2.6 Japan Dystrophin Consumption (2021-2032)
2.7 South Korea Dystrophin Consumption (2021-2032)
2.8 ASEAN Dystrophin Consumption (2021-2032)
2.9 India Dystrophin Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Dystrophin Production Value by Manufacturer (2021-2026)
3.2 World Dystrophin Production by Manufacturer (2021-2026)
3.3 World Dystrophin Average Price by Manufacturer (2021-2026)
3.4 Dystrophin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Dystrophin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Dystrophin in 2025
3.5.3 Global Concentration Ratios (CR8) for Dystrophin in 2025
3.6 Dystrophin Market: Overall Company Footprint Analysis
3.6.1 Dystrophin Market: Region Footprint
3.6.2 Dystrophin Market: Company Product Type Footprint
3.6.3 Dystrophin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Dystrophin Production Value Comparison
4.1.1 United States VS China: Dystrophin Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Dystrophin Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Dystrophin Production Comparison
4.2.1 United States VS China: Dystrophin Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Dystrophin Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Dystrophin Consumption Comparison
4.3.1 United States VS China: Dystrophin Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Dystrophin Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Dystrophin Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Dystrophin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Dystrophin Production Value (2021-2026)
4.4.3 United States Based Manufacturers Dystrophin Production (2021-2026)
4.5 China Based Dystrophin Manufacturers and Market Share
4.5.1 China Based Dystrophin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Dystrophin Production Value (2021-2026)
4.5.3 China Based Manufacturers Dystrophin Production (2021-2026)
4.6 Rest of World Based Dystrophin Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Dystrophin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Dystrophin Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Dystrophin Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Dystrophin Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 DS-5141
5.2.2 Biostrophin
5.2.3 BMBD-001
5.2.4 NS-065
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Dystrophin Production by Type (2021-2032)
5.3.2 World Dystrophin Production Value by Type (2021-2032)
5.3.3 World Dystrophin Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY TECHNOLOGY ROUTE
6.1 World Dystrophin Market Size Overview by Technology Route: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technology Route
6.2.1 Exon-skipping Therapy
6.2.2 Gene Therapy
6.2.3 Stop-codon Readthrough Therapy
6.2.4 Others
6.3 Market Segment by Technology Route
6.3.1 World Dystrophin Production by Technology Route (2021-2032)
6.3.2 World Dystrophin Production Value by Technology Route (2021-2032)
6.3.3 World Dystrophin Average Price by Technology Route (2021-2032)
7 MARKET ANALYSIS BY PRODUCT FORMAT
7.1 World Dystrophin Market Size Overview by Product Format: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Format
7.2.1 Therapeutic Drugs and Vectors
7.2.2 Antibodies and Assay Kits
7.2.3 Recombinant Proteins and Protein Fragments
7.2.4 Others
7.3 Market Segment by Product Format
7.3.1 World Dystrophin Production by Product Format (2021-2032)
7.3.2 World Dystrophin Production Value by Product Format (2021-2032)
7.3.3 World Dystrophin Average Price by Product Format (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Dystrophin Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Genetic Disorders
8.2.2 Musculoskeletal Disorders
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Dystrophin Production by Application (2021-2032)
8.3.2 World Dystrophin Production Value by Application (2021-2032)
8.3.3 World Dystrophin Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Sarepta Therapeutics
9.1.1 Sarepta Therapeutics Details
9.1.2 Sarepta Therapeutics Major Business
9.1.3 Sarepta Therapeutics Dystrophin Product and Services
9.1.4 Sarepta Therapeutics Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Sarepta Therapeutics Recent Developments/Updates
9.1.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
9.2 Roche
9.2.1 Roche Details
9.2.2 Roche Major Business
9.2.3 Roche Dystrophin Product and Services
9.2.4 Roche Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Roche Recent Developments/Updates
9.2.6 Roche Competitive Strengths & Weaknesses
9.3 Nippon Shinyaku
9.3.1 Nippon Shinyaku Details
9.3.2 Nippon Shinyaku Major Business
9.3.3 Nippon Shinyaku Dystrophin Product and Services
9.3.4 Nippon Shinyaku Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Nippon Shinyaku Recent Developments/Updates
9.3.6 Nippon Shinyaku Competitive Strengths & Weaknesses
9.4 PTC Therapeutics
9.4.1 PTC Therapeutics Details
9.4.2 PTC Therapeutics Major Business
9.4.3 PTC Therapeutics Dystrophin Product and Services
9.4.4 PTC Therapeutics Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 PTC Therapeutics Recent Developments/Updates
9.4.6 PTC Therapeutics Competitive Strengths & Weaknesses
9.5 REGENXBIO
9.5.1 REGENXBIO Details
9.5.2 REGENXBIO Major Business
9.5.3 REGENXBIO Dystrophin Product and Services
9.5.4 REGENXBIO Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 REGENXBIO Recent Developments/Updates
9.5.6 REGENXBIO Competitive Strengths & Weaknesses
9.6 Solid Biosciences
9.6.1 Solid Biosciences Details
9.6.2 Solid Biosciences Major Business
9.6.3 Solid Biosciences Dystrophin Product and Services
9.6.4 Solid Biosciences Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Solid Biosciences Recent Developments/Updates
9.6.6 Solid Biosciences Competitive Strengths & Weaknesses
9.7 Dyne Therapeutics
9.7.1 Dyne Therapeutics Details
9.7.2 Dyne Therapeutics Major Business
9.7.3 Dyne Therapeutics Dystrophin Product and Services
9.7.4 Dyne Therapeutics Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Dyne Therapeutics Recent Developments/Updates
9.7.6 Dyne Therapeutics Competitive Strengths & Weaknesses
9.8 Avidity Biosciences
9.8.1 Avidity Biosciences Details
9.8.2 Avidity Biosciences Major Business
9.8.3 Avidity Biosciences Dystrophin Product and Services
9.8.4 Avidity Biosciences Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Avidity Biosciences Recent Developments/Updates
9.8.6 Avidity Biosciences Competitive Strengths & Weaknesses
9.9 Wave Life Sciences
9.9.1 Wave Life Sciences Details
9.9.2 Wave Life Sciences Major Business
9.9.3 Wave Life Sciences Dystrophin Product and Services
9.9.4 Wave Life Sciences Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Wave Life Sciences Recent Developments/Updates
9.9.6 Wave Life Sciences Competitive Strengths & Weaknesses
9.10 Entrada Therapeutics
9.10.1 Entrada Therapeutics Details
9.10.2 Entrada Therapeutics Major Business
9.10.3 Entrada Therapeutics Dystrophin Product and Services
9.10.4 Entrada Therapeutics Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Entrada Therapeutics Recent Developments/Updates
9.10.6 Entrada Therapeutics Competitive Strengths & Weaknesses
9.11 Genethon
9.11.1 Genethon Details
9.11.2 Genethon Major Business
9.11.3 Genethon Dystrophin Product and Services
9.11.4 Genethon Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Genethon Recent Developments/Updates
9.11.6 Genethon Competitive Strengths & Weaknesses
9.12 Code Biotherapeutics
9.12.1 Code Biotherapeutics Details
9.12.2 Code Biotherapeutics Major Business
9.12.3 Code Biotherapeutics Dystrophin Product and Services
9.12.4 Code Biotherapeutics Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Code Biotherapeutics Recent Developments/Updates
9.12.6 Code Biotherapeutics Competitive Strengths & Weaknesses
9.13 Thermo Fisher Scientific
9.13.1 Thermo Fisher Scientific Details
9.13.2 Thermo Fisher Scientific Major Business
9.13.3 Thermo Fisher Scientific Dystrophin Product and Services
9.13.4 Thermo Fisher Scientific Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Thermo Fisher Scientific Recent Developments/Updates
9.13.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.14 Abcam
9.14.1 Abcam Details
9.14.2 Abcam Major Business
9.14.3 Abcam Dystrophin Product and Services
9.14.4 Abcam Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Abcam Recent Developments/Updates
9.14.6 Abcam Competitive Strengths & Weaknesses
9.15 Merck
9.15.1 Merck Details
9.15.2 Merck Major Business
9.15.3 Merck Dystrophin Product and Services
9.15.4 Merck Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Merck Recent Developments/Updates
9.15.6 Merck Competitive Strengths & Weaknesses
9.16 Bio-Techne
9.16.1 Bio-Techne Details
9.16.2 Bio-Techne Major Business
9.16.3 Bio-Techne Dystrophin Product and Services
9.16.4 Bio-Techne Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Bio-Techne Recent Developments/Updates
9.16.6 Bio-Techne Competitive Strengths & Weaknesses
9.17 Proteintech
9.17.1 Proteintech Details
9.17.2 Proteintech Major Business
9.17.3 Proteintech Dystrophin Product and Services
9.17.4 Proteintech Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Proteintech Recent Developments/Updates
9.17.6 Proteintech Competitive Strengths & Weaknesses
9.18 OriGene
9.18.1 OriGene Details
9.18.2 OriGene Major Business
9.18.3 OriGene Dystrophin Product and Services
9.18.4 OriGene Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 OriGene Recent Developments/Updates
9.18.6 OriGene Competitive Strengths & Weaknesses
9.19 Cell Signaling Technology
9.19.1 Cell Signaling Technology Details
9.19.2 Cell Signaling Technology Major Business
9.19.3 Cell Signaling Technology Dystrophin Product and Services
9.19.4 Cell Signaling Technology Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Cell Signaling Technology Recent Developments/Updates
9.19.6 Cell Signaling Technology Competitive Strengths & Weaknesses
9.20 Santa Cruz Biotechnology
9.20.1 Santa Cruz Biotechnology Details
9.20.2 Santa Cruz Biotechnology Major Business
9.20.3 Santa Cruz Biotechnology Dystrophin Product and Services
9.20.4 Santa Cruz Biotechnology Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Santa Cruz Biotechnology Recent Developments/Updates
9.20.6 Santa Cruz Biotechnology Competitive Strengths & Weaknesses
9.21 Atlas Antibodies
9.21.1 Atlas Antibodies Details
9.21.2 Atlas Antibodies Major Business
9.21.3 Atlas Antibodies Dystrophin Product and Services
9.21.4 Atlas Antibodies Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.21.5 Atlas Antibodies Recent Developments/Updates
9.21.6 Atlas Antibodies Competitive Strengths & Weaknesses
9.22 Leica Biosystems
9.22.1 Leica Biosystems Details
9.22.2 Leica Biosystems Major Business
9.22.3 Leica Biosystems Dystrophin Product and Services
9.22.4 Leica Biosystems Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.22.5 Leica Biosystems Recent Developments/Updates
9.22.6 Leica Biosystems Competitive Strengths & Weaknesses
9.23 Creative BioMart
9.23.1 Creative BioMart Details
9.23.2 Creative BioMart Major Business
9.23.3 Creative BioMart Dystrophin Product and Services
9.23.4 Creative BioMart Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.23.5 Creative BioMart Recent Developments/Updates
9.23.6 Creative BioMart Competitive Strengths & Weaknesses
9.24 MyBioSource
9.24.1 MyBioSource Details
9.24.2 MyBioSource Major Business
9.24.3 MyBioSource Dystrophin Product and Services
9.24.4 MyBioSource Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.24.5 MyBioSource Recent Developments/Updates
9.24.6 MyBioSource Competitive Strengths & Weaknesses
9.25 NSJ Bioreagents
9.25.1 NSJ Bioreagents Details
9.25.2 NSJ Bioreagents Major Business
9.25.3 NSJ Bioreagents Dystrophin Product and Services
9.25.4 NSJ Bioreagents Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.25.5 NSJ Bioreagents Recent Developments/Updates
9.25.6 NSJ Bioreagents Competitive Strengths & Weaknesses
9.26 Abbexa
9.26.1 Abbexa Details
9.26.2 Abbexa Major Business
9.26.3 Abbexa Dystrophin Product and Services
9.26.4 Abbexa Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.26.5 Abbexa Recent Developments/Updates
9.26.6 Abbexa Competitive Strengths & Weaknesses
9.27 Abnova
9.27.1 Abnova Details
9.27.2 Abnova Major Business
9.27.3 Abnova Dystrophin Product and Services
9.27.4 Abnova Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.27.5 Abnova Recent Developments/Updates
9.27.6 Abnova Competitive Strengths & Weaknesses
9.28 Boster Biological Technology
9.28.1 Boster Biological Technology Details
9.28.2 Boster Biological Technology Major Business
9.28.3 Boster Biological Technology Dystrophin Product and Services
9.28.4 Boster Biological Technology Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.28.5 Boster Biological Technology Recent Developments/Updates
9.28.6 Boster Biological Technology Competitive Strengths & Weaknesses
9.29 Cloud-Clone
9.29.1 Cloud-Clone Details
9.29.2 Cloud-Clone Major Business
9.29.3 Cloud-Clone Dystrophin Product and Services
9.29.4 Cloud-Clone Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.29.5 Cloud-Clone Recent Developments/Updates
9.29.6 Cloud-Clone Competitive Strengths & Weaknesses
9.30 FineTest
9.30.1 FineTest Details
9.30.2 FineTest Major Business
9.30.3 FineTest Dystrophin Product and Services
9.30.4 FineTest Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.30.5 FineTest Recent Developments/Updates
9.30.6 FineTest Competitive Strengths & Weaknesses
9.31 CUSABIO
9.31.1 CUSABIO Details
9.31.2 CUSABIO Major Business
9.31.3 CUSABIO Dystrophin Product and Services
9.31.4 CUSABIO Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.31.5 CUSABIO Recent Developments/Updates
9.31.6 CUSABIO Competitive Strengths & Weaknesses
9.32 Assay Genie
9.32.1 Assay Genie Details
9.32.2 Assay Genie Major Business
9.32.3 Assay Genie Dystrophin Product and Services
9.32.4 Assay Genie Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.32.5 Assay Genie Recent Developments/Updates
9.32.6 Assay Genie Competitive Strengths & Weaknesses
9.33 Bioss Antibodies
9.33.1 Bioss Antibodies Details
9.33.2 Bioss Antibodies Major Business
9.33.3 Bioss Antibodies Dystrophin Product and Services
9.33.4 Bioss Antibodies Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.33.5 Bioss Antibodies Recent Developments/Updates
9.33.6 Bioss Antibodies Competitive Strengths & Weaknesses
9.34 XpressBio
9.34.1 XpressBio Details
9.34.2 XpressBio Major Business
9.34.3 XpressBio Dystrophin Product and Services
9.34.4 XpressBio Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.34.5 XpressBio Recent Developments/Updates
9.34.6 XpressBio Competitive Strengths & Weaknesses
9.35 BioGenex
9.35.1 BioGenex Details
9.35.2 BioGenex Major Business
9.35.3 BioGenex Dystrophin Product and Services
9.35.4 BioGenex Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.35.5 BioGenex Recent Developments/Updates
9.35.6 BioGenex Competitive Strengths & Weaknesses
9.36 United States Biological
9.36.1 United States Biological Details
9.36.2 United States Biological Major Business
9.36.3 United States Biological Dystrophin Product and Services
9.36.4 United States Biological Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.36.5 United States Biological Recent Developments/Updates
9.36.6 United States Biological Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Dystrophin Industry Chain
10.2 Dystrophin Upstream Analysis
10.2.1 Dystrophin Core Raw Materials
10.2.2 Main Manufacturers of Dystrophin Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Dystrophin Production Mode
10.6 Dystrophin Procurement Model
10.7 Dystrophin Industry Sales Model and Sales Channels
10.7.1 Dystrophin Sales Model
10.7.2 Dystrophin Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Dystrophin Introduction
1.2 World Dystrophin Supply & Forecast
1.2.1 World Dystrophin Production Value (2021 & 2025 & 2032)
1.2.2 World Dystrophin Production (2021-2032)
1.2.3 World Dystrophin Pricing Trends (2021-2032)
1.3 World Dystrophin Production by Region (Based on Production Site)
1.3.1 World Dystrophin Production Value by Region (2021-2032)
1.3.2 World Dystrophin Production by Region (2021-2032)
1.3.3 World Dystrophin Average Price by Region (2021-2032)
1.3.4 North America Dystrophin Production (2021-2032)
1.3.5 Europe Dystrophin Production (2021-2032)
1.3.6 China Dystrophin Production (2021-2032)
1.3.7 Japan Dystrophin Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Dystrophin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Dystrophin Major Market Trends
2 DEMAND SUMMARY
2.1 World Dystrophin Demand (2021-2032)
2.2 World Dystrophin Consumption by Region
2.2.1 World Dystrophin Consumption by Region (2021-2026)
2.2.2 World Dystrophin Consumption Forecast by Region (2027-2032)
2.3 United States Dystrophin Consumption (2021-2032)
2.4 China Dystrophin Consumption (2021-2032)
2.5 Europe Dystrophin Consumption (2021-2032)
2.6 Japan Dystrophin Consumption (2021-2032)
2.7 South Korea Dystrophin Consumption (2021-2032)
2.8 ASEAN Dystrophin Consumption (2021-2032)
2.9 India Dystrophin Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Dystrophin Production Value by Manufacturer (2021-2026)
3.2 World Dystrophin Production by Manufacturer (2021-2026)
3.3 World Dystrophin Average Price by Manufacturer (2021-2026)
3.4 Dystrophin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Dystrophin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Dystrophin in 2025
3.5.3 Global Concentration Ratios (CR8) for Dystrophin in 2025
3.6 Dystrophin Market: Overall Company Footprint Analysis
3.6.1 Dystrophin Market: Region Footprint
3.6.2 Dystrophin Market: Company Product Type Footprint
3.6.3 Dystrophin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Dystrophin Production Value Comparison
4.1.1 United States VS China: Dystrophin Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Dystrophin Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Dystrophin Production Comparison
4.2.1 United States VS China: Dystrophin Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Dystrophin Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Dystrophin Consumption Comparison
4.3.1 United States VS China: Dystrophin Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Dystrophin Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Dystrophin Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Dystrophin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Dystrophin Production Value (2021-2026)
4.4.3 United States Based Manufacturers Dystrophin Production (2021-2026)
4.5 China Based Dystrophin Manufacturers and Market Share
4.5.1 China Based Dystrophin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Dystrophin Production Value (2021-2026)
4.5.3 China Based Manufacturers Dystrophin Production (2021-2026)
4.6 Rest of World Based Dystrophin Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Dystrophin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Dystrophin Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Dystrophin Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Dystrophin Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 DS-5141
5.2.2 Biostrophin
5.2.3 BMBD-001
5.2.4 NS-065
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Dystrophin Production by Type (2021-2032)
5.3.2 World Dystrophin Production Value by Type (2021-2032)
5.3.3 World Dystrophin Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY TECHNOLOGY ROUTE
6.1 World Dystrophin Market Size Overview by Technology Route: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technology Route
6.2.1 Exon-skipping Therapy
6.2.2 Gene Therapy
6.2.3 Stop-codon Readthrough Therapy
6.2.4 Others
6.3 Market Segment by Technology Route
6.3.1 World Dystrophin Production by Technology Route (2021-2032)
6.3.2 World Dystrophin Production Value by Technology Route (2021-2032)
6.3.3 World Dystrophin Average Price by Technology Route (2021-2032)
7 MARKET ANALYSIS BY PRODUCT FORMAT
7.1 World Dystrophin Market Size Overview by Product Format: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Format
7.2.1 Therapeutic Drugs and Vectors
7.2.2 Antibodies and Assay Kits
7.2.3 Recombinant Proteins and Protein Fragments
7.2.4 Others
7.3 Market Segment by Product Format
7.3.1 World Dystrophin Production by Product Format (2021-2032)
7.3.2 World Dystrophin Production Value by Product Format (2021-2032)
7.3.3 World Dystrophin Average Price by Product Format (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Dystrophin Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Genetic Disorders
8.2.2 Musculoskeletal Disorders
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Dystrophin Production by Application (2021-2032)
8.3.2 World Dystrophin Production Value by Application (2021-2032)
8.3.3 World Dystrophin Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Sarepta Therapeutics
9.1.1 Sarepta Therapeutics Details
9.1.2 Sarepta Therapeutics Major Business
9.1.3 Sarepta Therapeutics Dystrophin Product and Services
9.1.4 Sarepta Therapeutics Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Sarepta Therapeutics Recent Developments/Updates
9.1.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
9.2 Roche
9.2.1 Roche Details
9.2.2 Roche Major Business
9.2.3 Roche Dystrophin Product and Services
9.2.4 Roche Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Roche Recent Developments/Updates
9.2.6 Roche Competitive Strengths & Weaknesses
9.3 Nippon Shinyaku
9.3.1 Nippon Shinyaku Details
9.3.2 Nippon Shinyaku Major Business
9.3.3 Nippon Shinyaku Dystrophin Product and Services
9.3.4 Nippon Shinyaku Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Nippon Shinyaku Recent Developments/Updates
9.3.6 Nippon Shinyaku Competitive Strengths & Weaknesses
9.4 PTC Therapeutics
9.4.1 PTC Therapeutics Details
9.4.2 PTC Therapeutics Major Business
9.4.3 PTC Therapeutics Dystrophin Product and Services
9.4.4 PTC Therapeutics Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 PTC Therapeutics Recent Developments/Updates
9.4.6 PTC Therapeutics Competitive Strengths & Weaknesses
9.5 REGENXBIO
9.5.1 REGENXBIO Details
9.5.2 REGENXBIO Major Business
9.5.3 REGENXBIO Dystrophin Product and Services
9.5.4 REGENXBIO Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 REGENXBIO Recent Developments/Updates
9.5.6 REGENXBIO Competitive Strengths & Weaknesses
9.6 Solid Biosciences
9.6.1 Solid Biosciences Details
9.6.2 Solid Biosciences Major Business
9.6.3 Solid Biosciences Dystrophin Product and Services
9.6.4 Solid Biosciences Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Solid Biosciences Recent Developments/Updates
9.6.6 Solid Biosciences Competitive Strengths & Weaknesses
9.7 Dyne Therapeutics
9.7.1 Dyne Therapeutics Details
9.7.2 Dyne Therapeutics Major Business
9.7.3 Dyne Therapeutics Dystrophin Product and Services
9.7.4 Dyne Therapeutics Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Dyne Therapeutics Recent Developments/Updates
9.7.6 Dyne Therapeutics Competitive Strengths & Weaknesses
9.8 Avidity Biosciences
9.8.1 Avidity Biosciences Details
9.8.2 Avidity Biosciences Major Business
9.8.3 Avidity Biosciences Dystrophin Product and Services
9.8.4 Avidity Biosciences Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Avidity Biosciences Recent Developments/Updates
9.8.6 Avidity Biosciences Competitive Strengths & Weaknesses
9.9 Wave Life Sciences
9.9.1 Wave Life Sciences Details
9.9.2 Wave Life Sciences Major Business
9.9.3 Wave Life Sciences Dystrophin Product and Services
9.9.4 Wave Life Sciences Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Wave Life Sciences Recent Developments/Updates
9.9.6 Wave Life Sciences Competitive Strengths & Weaknesses
9.10 Entrada Therapeutics
9.10.1 Entrada Therapeutics Details
9.10.2 Entrada Therapeutics Major Business
9.10.3 Entrada Therapeutics Dystrophin Product and Services
9.10.4 Entrada Therapeutics Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Entrada Therapeutics Recent Developments/Updates
9.10.6 Entrada Therapeutics Competitive Strengths & Weaknesses
9.11 Genethon
9.11.1 Genethon Details
9.11.2 Genethon Major Business
9.11.3 Genethon Dystrophin Product and Services
9.11.4 Genethon Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Genethon Recent Developments/Updates
9.11.6 Genethon Competitive Strengths & Weaknesses
9.12 Code Biotherapeutics
9.12.1 Code Biotherapeutics Details
9.12.2 Code Biotherapeutics Major Business
9.12.3 Code Biotherapeutics Dystrophin Product and Services
9.12.4 Code Biotherapeutics Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Code Biotherapeutics Recent Developments/Updates
9.12.6 Code Biotherapeutics Competitive Strengths & Weaknesses
9.13 Thermo Fisher Scientific
9.13.1 Thermo Fisher Scientific Details
9.13.2 Thermo Fisher Scientific Major Business
9.13.3 Thermo Fisher Scientific Dystrophin Product and Services
9.13.4 Thermo Fisher Scientific Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Thermo Fisher Scientific Recent Developments/Updates
9.13.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.14 Abcam
9.14.1 Abcam Details
9.14.2 Abcam Major Business
9.14.3 Abcam Dystrophin Product and Services
9.14.4 Abcam Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Abcam Recent Developments/Updates
9.14.6 Abcam Competitive Strengths & Weaknesses
9.15 Merck
9.15.1 Merck Details
9.15.2 Merck Major Business
9.15.3 Merck Dystrophin Product and Services
9.15.4 Merck Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Merck Recent Developments/Updates
9.15.6 Merck Competitive Strengths & Weaknesses
9.16 Bio-Techne
9.16.1 Bio-Techne Details
9.16.2 Bio-Techne Major Business
9.16.3 Bio-Techne Dystrophin Product and Services
9.16.4 Bio-Techne Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Bio-Techne Recent Developments/Updates
9.16.6 Bio-Techne Competitive Strengths & Weaknesses
9.17 Proteintech
9.17.1 Proteintech Details
9.17.2 Proteintech Major Business
9.17.3 Proteintech Dystrophin Product and Services
9.17.4 Proteintech Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Proteintech Recent Developments/Updates
9.17.6 Proteintech Competitive Strengths & Weaknesses
9.18 OriGene
9.18.1 OriGene Details
9.18.2 OriGene Major Business
9.18.3 OriGene Dystrophin Product and Services
9.18.4 OriGene Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 OriGene Recent Developments/Updates
9.18.6 OriGene Competitive Strengths & Weaknesses
9.19 Cell Signaling Technology
9.19.1 Cell Signaling Technology Details
9.19.2 Cell Signaling Technology Major Business
9.19.3 Cell Signaling Technology Dystrophin Product and Services
9.19.4 Cell Signaling Technology Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Cell Signaling Technology Recent Developments/Updates
9.19.6 Cell Signaling Technology Competitive Strengths & Weaknesses
9.20 Santa Cruz Biotechnology
9.20.1 Santa Cruz Biotechnology Details
9.20.2 Santa Cruz Biotechnology Major Business
9.20.3 Santa Cruz Biotechnology Dystrophin Product and Services
9.20.4 Santa Cruz Biotechnology Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Santa Cruz Biotechnology Recent Developments/Updates
9.20.6 Santa Cruz Biotechnology Competitive Strengths & Weaknesses
9.21 Atlas Antibodies
9.21.1 Atlas Antibodies Details
9.21.2 Atlas Antibodies Major Business
9.21.3 Atlas Antibodies Dystrophin Product and Services
9.21.4 Atlas Antibodies Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.21.5 Atlas Antibodies Recent Developments/Updates
9.21.6 Atlas Antibodies Competitive Strengths & Weaknesses
9.22 Leica Biosystems
9.22.1 Leica Biosystems Details
9.22.2 Leica Biosystems Major Business
9.22.3 Leica Biosystems Dystrophin Product and Services
9.22.4 Leica Biosystems Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.22.5 Leica Biosystems Recent Developments/Updates
9.22.6 Leica Biosystems Competitive Strengths & Weaknesses
9.23 Creative BioMart
9.23.1 Creative BioMart Details
9.23.2 Creative BioMart Major Business
9.23.3 Creative BioMart Dystrophin Product and Services
9.23.4 Creative BioMart Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.23.5 Creative BioMart Recent Developments/Updates
9.23.6 Creative BioMart Competitive Strengths & Weaknesses
9.24 MyBioSource
9.24.1 MyBioSource Details
9.24.2 MyBioSource Major Business
9.24.3 MyBioSource Dystrophin Product and Services
9.24.4 MyBioSource Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.24.5 MyBioSource Recent Developments/Updates
9.24.6 MyBioSource Competitive Strengths & Weaknesses
9.25 NSJ Bioreagents
9.25.1 NSJ Bioreagents Details
9.25.2 NSJ Bioreagents Major Business
9.25.3 NSJ Bioreagents Dystrophin Product and Services
9.25.4 NSJ Bioreagents Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.25.5 NSJ Bioreagents Recent Developments/Updates
9.25.6 NSJ Bioreagents Competitive Strengths & Weaknesses
9.26 Abbexa
9.26.1 Abbexa Details
9.26.2 Abbexa Major Business
9.26.3 Abbexa Dystrophin Product and Services
9.26.4 Abbexa Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.26.5 Abbexa Recent Developments/Updates
9.26.6 Abbexa Competitive Strengths & Weaknesses
9.27 Abnova
9.27.1 Abnova Details
9.27.2 Abnova Major Business
9.27.3 Abnova Dystrophin Product and Services
9.27.4 Abnova Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.27.5 Abnova Recent Developments/Updates
9.27.6 Abnova Competitive Strengths & Weaknesses
9.28 Boster Biological Technology
9.28.1 Boster Biological Technology Details
9.28.2 Boster Biological Technology Major Business
9.28.3 Boster Biological Technology Dystrophin Product and Services
9.28.4 Boster Biological Technology Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.28.5 Boster Biological Technology Recent Developments/Updates
9.28.6 Boster Biological Technology Competitive Strengths & Weaknesses
9.29 Cloud-Clone
9.29.1 Cloud-Clone Details
9.29.2 Cloud-Clone Major Business
9.29.3 Cloud-Clone Dystrophin Product and Services
9.29.4 Cloud-Clone Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.29.5 Cloud-Clone Recent Developments/Updates
9.29.6 Cloud-Clone Competitive Strengths & Weaknesses
9.30 FineTest
9.30.1 FineTest Details
9.30.2 FineTest Major Business
9.30.3 FineTest Dystrophin Product and Services
9.30.4 FineTest Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.30.5 FineTest Recent Developments/Updates
9.30.6 FineTest Competitive Strengths & Weaknesses
9.31 CUSABIO
9.31.1 CUSABIO Details
9.31.2 CUSABIO Major Business
9.31.3 CUSABIO Dystrophin Product and Services
9.31.4 CUSABIO Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.31.5 CUSABIO Recent Developments/Updates
9.31.6 CUSABIO Competitive Strengths & Weaknesses
9.32 Assay Genie
9.32.1 Assay Genie Details
9.32.2 Assay Genie Major Business
9.32.3 Assay Genie Dystrophin Product and Services
9.32.4 Assay Genie Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.32.5 Assay Genie Recent Developments/Updates
9.32.6 Assay Genie Competitive Strengths & Weaknesses
9.33 Bioss Antibodies
9.33.1 Bioss Antibodies Details
9.33.2 Bioss Antibodies Major Business
9.33.3 Bioss Antibodies Dystrophin Product and Services
9.33.4 Bioss Antibodies Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.33.5 Bioss Antibodies Recent Developments/Updates
9.33.6 Bioss Antibodies Competitive Strengths & Weaknesses
9.34 XpressBio
9.34.1 XpressBio Details
9.34.2 XpressBio Major Business
9.34.3 XpressBio Dystrophin Product and Services
9.34.4 XpressBio Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.34.5 XpressBio Recent Developments/Updates
9.34.6 XpressBio Competitive Strengths & Weaknesses
9.35 BioGenex
9.35.1 BioGenex Details
9.35.2 BioGenex Major Business
9.35.3 BioGenex Dystrophin Product and Services
9.35.4 BioGenex Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.35.5 BioGenex Recent Developments/Updates
9.35.6 BioGenex Competitive Strengths & Weaknesses
9.36 United States Biological
9.36.1 United States Biological Details
9.36.2 United States Biological Major Business
9.36.3 United States Biological Dystrophin Product and Services
9.36.4 United States Biological Dystrophin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.36.5 United States Biological Recent Developments/Updates
9.36.6 United States Biological Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Dystrophin Industry Chain
10.2 Dystrophin Upstream Analysis
10.2.1 Dystrophin Core Raw Materials
10.2.2 Main Manufacturers of Dystrophin Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Dystrophin Production Mode
10.6 Dystrophin Procurement Model
10.7 Dystrophin Industry Sales Model and Sales Channels
10.7.1 Dystrophin Sales Model
10.7.2 Dystrophin Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Dystrophin Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Dystrophin Production Value by Region (2021-2026) & (USD Million)
Table 3. World Dystrophin Production Value by Region (2027-2032) & (USD Million)
Table 4. World Dystrophin Production Value Market Share by Region (2021-2026)
Table 5. World Dystrophin Production Value Market Share by Region (2027-2032)
Table 6. World Dystrophin Production by Region (2021-2026) & (K Dose)
Table 7. World Dystrophin Production by Region (2027-2032) & (K Dose)
Table 8. World Dystrophin Production Market Share by Region (2021-2026)
Table 9. World Dystrophin Production Market Share by Region (2027-2032)
Table 10. World Dystrophin Average Price by Region (2021-2026) & (USD/Pcs)
Table 11. World Dystrophin Average Price by Region (2027-2032) & (USD/Pcs)
Table 12. Dystrophin Major Market Trends
Table 13. World Dystrophin Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Dystrophin Consumption by Region (2021-2026) & (K Dose)
Table 15. World Dystrophin Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Dystrophin Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Dystrophin Producers in 2025
Table 18. World Dystrophin Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Dystrophin Producers in 2025
Table 20. World Dystrophin Average Price by Manufacturer (2021-2026) & (USD/Pcs)
Table 21. Global Dystrophin Company Evaluation Quadrant
Table 22. World Dystrophin Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Dystrophin Production Site of Key Manufacturer
Table 24. Dystrophin Market: Company Product Type Footprint
Table 25. Dystrophin Market: Company Product Application Footprint
Table 26. Dystrophin Competitive Factors
Table 27. Dystrophin New Entrant and Capacity Expansion Plans
Table 28. Dystrophin Mergers & Acquisitions Activity
Table 29. United States VS China Dystrophin Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Dystrophin Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Dystrophin Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Dystrophin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Dystrophin Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Dystrophin Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Dystrophin Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Dystrophin Production Market Share (2021-2026)
Table 37. China Based Dystrophin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Dystrophin Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Dystrophin Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Dystrophin Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Dystrophin Production Market Share (2021-2026)
Table 42. Rest of World Based Dystrophin Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Dystrophin Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Dystrophin Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Dystrophin Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Dystrophin Production Market Share (2021-2026)
Table 47. World Dystrophin Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Dystrophin Production by Type (2021-2026) & (K Dose)
Table 49. World Dystrophin Production by Type (2027-2032) & (K Dose)
Table 50. World Dystrophin Production Value by Type (2021-2026) & (USD Million)
Table 51. World Dystrophin Production Value by Type (2027-2032) & (USD Million)
Table 52. World Dystrophin Average Price by Type (2021-2026) & (USD/Pcs)
Table 53. World Dystrophin Average Price by Type (2027-2032) & (USD/Pcs)
Table 54. World Dystrophin Production Value by Technology Route, (USD Million), 2021 & 2025 & 2032
Table 55. World Dystrophin Production by Technology Route (2021-2026) & (K Dose)
Table 56. World Dystrophin Production by Technology Route (2027-2032) & (K Dose)
Table 57. World Dystrophin Production Value by Technology Route (2021-2026) & (USD Million)
Table 58. World Dystrophin Production Value by Technology Route (2027-2032) & (USD Million)
Table 59. World Dystrophin Average Price by Technology Route (2021-2026) & (USD/Pcs)
Table 60. World Dystrophin Average Price by Technology Route (2027-2032) & (USD/Pcs)
Table 61. World Dystrophin Production Value by Product Format, (USD Million), 2021 & 2025 & 2032
Table 62. World Dystrophin Production by Product Format (2021-2026) & (K Dose)
Table 63. World Dystrophin Production by Product Format (2027-2032) & (K Dose)
Table 64. World Dystrophin Production Value by Product Format (2021-2026) & (USD Million)
Table 65. World Dystrophin Production Value by Product Format (2027-2032) & (USD Million)
Table 66. World Dystrophin Average Price by Product Format (2021-2026) & (USD/Pcs)
Table 67. World Dystrophin Average Price by Product Format (2027-2032) & (USD/Pcs)
Table 68. World Dystrophin Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Dystrophin Production by Application (2021-2026) & (K Dose)
Table 70. World Dystrophin Production by Application (2027-2032) & (K Dose)
Table 71. World Dystrophin Production Value by Application (2021-2026) & (USD Million)
Table 72. World Dystrophin Production Value by Application (2027-2032) & (USD Million)
Table 73. World Dystrophin Average Price by Application (2021-2026) & (USD/Pcs)
Table 74. World Dystrophin Average Price by Application (2027-2032) & (USD/Pcs)
Table 75. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
Table 76. Sarepta Therapeutics Major Business
Table 77. Sarepta Therapeutics Dystrophin Product and Services
Table 78. Sarepta Therapeutics Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Sarepta Therapeutics Recent Developments/Updates
Table 80. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 81. Roche Basic Information, Manufacturing Base and Competitors
Table 82. Roche Major Business
Table 83. Roche Dystrophin Product and Services
Table 84. Roche Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Roche Recent Developments/Updates
Table 86. Roche Competitive Strengths & Weaknesses
Table 87. Nippon Shinyaku Basic Information, Manufacturing Base and Competitors
Table 88. Nippon Shinyaku Major Business
Table 89. Nippon Shinyaku Dystrophin Product and Services
Table 90. Nippon Shinyaku Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Nippon Shinyaku Recent Developments/Updates
Table 92. Nippon Shinyaku Competitive Strengths & Weaknesses
Table 93. PTC Therapeutics Basic Information, Manufacturing Base and Competitors
Table 94. PTC Therapeutics Major Business
Table 95. PTC Therapeutics Dystrophin Product and Services
Table 96. PTC Therapeutics Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. PTC Therapeutics Recent Developments/Updates
Table 98. PTC Therapeutics Competitive Strengths & Weaknesses
Table 99. REGENXBIO Basic Information, Manufacturing Base and Competitors
Table 100. REGENXBIO Major Business
Table 101. REGENXBIO Dystrophin Product and Services
Table 102. REGENXBIO Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. REGENXBIO Recent Developments/Updates
Table 104. REGENXBIO Competitive Strengths & Weaknesses
Table 105. Solid Biosciences Basic Information, Manufacturing Base and Competitors
Table 106. Solid Biosciences Major Business
Table 107. Solid Biosciences Dystrophin Product and Services
Table 108. Solid Biosciences Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Solid Biosciences Recent Developments/Updates
Table 110. Solid Biosciences Competitive Strengths & Weaknesses
Table 111. Dyne Therapeutics Basic Information, Manufacturing Base and Competitors
Table 112. Dyne Therapeutics Major Business
Table 113. Dyne Therapeutics Dystrophin Product and Services
Table 114. Dyne Therapeutics Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Dyne Therapeutics Recent Developments/Updates
Table 116. Dyne Therapeutics Competitive Strengths & Weaknesses
Table 117. Avidity Biosciences Basic Information, Manufacturing Base and Competitors
Table 118. Avidity Biosciences Major Business
Table 119. Avidity Biosciences Dystrophin Product and Services
Table 120. Avidity Biosciences Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Avidity Biosciences Recent Developments/Updates
Table 122. Avidity Biosciences Competitive Strengths & Weaknesses
Table 123. Wave Life Sciences Basic Information, Manufacturing Base and Competitors
Table 124. Wave Life Sciences Major Business
Table 125. Wave Life Sciences Dystrophin Product and Services
Table 126. Wave Life Sciences Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Wave Life Sciences Recent Developments/Updates
Table 128. Wave Life Sciences Competitive Strengths & Weaknesses
Table 129. Entrada Therapeutics Basic Information, Manufacturing Base and Competitors
Table 130. Entrada Therapeutics Major Business
Table 131. Entrada Therapeutics Dystrophin Product and Services
Table 132. Entrada Therapeutics Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Entrada Therapeutics Recent Developments/Updates
Table 134. Entrada Therapeutics Competitive Strengths & Weaknesses
Table 135. Genethon Basic Information, Manufacturing Base and Competitors
Table 136. Genethon Major Business
Table 137. Genethon Dystrophin Product and Services
Table 138. Genethon Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Genethon Recent Developments/Updates
Table 140. Genethon Competitive Strengths & Weaknesses
Table 141. Code Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 142. Code Biotherapeutics Major Business
Table 143. Code Biotherapeutics Dystrophin Product and Services
Table 144. Code Biotherapeutics Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Code Biotherapeutics Recent Developments/Updates
Table 146. Code Biotherapeutics Competitive Strengths & Weaknesses
Table 147. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 148. Thermo Fisher Scientific Major Business
Table 149. Thermo Fisher Scientific Dystrophin Product and Services
Table 150. Thermo Fisher Scientific Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Thermo Fisher Scientific Recent Developments/Updates
Table 152. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 153. Abcam Basic Information, Manufacturing Base and Competitors
Table 154. Abcam Major Business
Table 155. Abcam Dystrophin Product and Services
Table 156. Abcam Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Abcam Recent Developments/Updates
Table 158. Abcam Competitive Strengths & Weaknesses
Table 159. Merck Basic Information, Manufacturing Base and Competitors
Table 160. Merck Major Business
Table 161. Merck Dystrophin Product and Services
Table 162. Merck Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Merck Recent Developments/Updates
Table 164. Merck Competitive Strengths & Weaknesses
Table 165. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 166. Bio-Techne Major Business
Table 167. Bio-Techne Dystrophin Product and Services
Table 168. Bio-Techne Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Bio-Techne Recent Developments/Updates
Table 170. Bio-Techne Competitive Strengths & Weaknesses
Table 171. Proteintech Basic Information, Manufacturing Base and Competitors
Table 172. Proteintech Major Business
Table 173. Proteintech Dystrophin Product and Services
Table 174. Proteintech Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Proteintech Recent Developments/Updates
Table 176. Proteintech Competitive Strengths & Weaknesses
Table 177. OriGene Basic Information, Manufacturing Base and Competitors
Table 178. OriGene Major Business
Table 179. OriGene Dystrophin Product and Services
Table 180. OriGene Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. OriGene Recent Developments/Updates
Table 182. OriGene Competitive Strengths & Weaknesses
Table 183. Cell Signaling Technology Basic Information, Manufacturing Base and Competitors
Table 184. Cell Signaling Technology Major Business
Table 185. Cell Signaling Technology Dystrophin Product and Services
Table 186. Cell Signaling Technology Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Cell Signaling Technology Recent Developments/Updates
Table 188. Cell Signaling Technology Competitive Strengths & Weaknesses
Table 189. Santa Cruz Biotechnology Basic Information, Manufacturing Base and Competitors
Table 190. Santa Cruz Biotechnology Major Business
Table 191. Santa Cruz Biotechnology Dystrophin Product and Services
Table 192. Santa Cruz Biotechnology Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Santa Cruz Biotechnology Recent Developments/Updates
Table 194. Santa Cruz Biotechnology Competitive Strengths & Weaknesses
Table 195. Atlas Antibodies Basic Information, Manufacturing Base and Competitors
Table 196. Atlas Antibodies Major Business
Table 197. Atlas Antibodies Dystrophin Product and Services
Table 198. Atlas Antibodies Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 199. Atlas Antibodies Recent Developments/Updates
Table 200. Atlas Antibodies Competitive Strengths & Weaknesses
Table 201. Leica Biosystems Basic Information, Manufacturing Base and Competitors
Table 202. Leica Biosystems Major Business
Table 203. Leica Biosystems Dystrophin Product and Services
Table 204. Leica Biosystems Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Leica Biosystems Recent Developments/Updates
Table 206. Leica Biosystems Competitive Strengths & Weaknesses
Table 207. Creative BioMart Basic Information, Manufacturing Base and Competitors
Table 208. Creative BioMart Major Business
Table 209. Creative BioMart Dystrophin Product and Services
Table 210. Creative BioMart Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 211. Creative BioMart Recent Developments/Updates
Table 212. Creative BioMart Competitive Strengths & Weaknesses
Table 213. MyBioSource Basic Information, Manufacturing Base and Competitors
Table 214. MyBioSource Major Business
Table 215. MyBioSource Dystrophin Product and Services
Table 216. MyBioSource Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 217. MyBioSource Recent Developments/Updates
Table 218. MyBioSource Competitive Strengths & Weaknesses
Table 219. NSJ Bioreagents Basic Information, Manufacturing Base and Competitors
Table 220. NSJ Bioreagents Major Business
Table 221. NSJ Bioreagents Dystrophin Product and Services
Table 222. NSJ Bioreagents Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 223. NSJ Bioreagents Recent Developments/Updates
Table 224. NSJ Bioreagents Competitive Strengths & Weaknesses
Table 225. Abbexa Basic Information, Manufacturing Base and Competitors
Table 226. Abbexa Major Business
Table 227. Abbexa Dystrophin Product and Services
Table 228. Abbexa Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 229. Abbexa Recent Developments/Updates
Table 230. Abbexa Competitive Strengths & Weaknesses
Table 231. Abnova Basic Information, Manufacturing Base and Competitors
Table 232. Abnova Major Business
Table 233. Abnova Dystrophin Product and Services
Table 234. Abnova Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 235. Abnova Recent Developments/Updates
Table 236. Abnova Competitive Strengths & Weaknesses
Table 237. Boster Biological Technology Basic Information, Manufacturing Base and Competitors
Table 238. Boster Biological Technology Major Business
Table 239. Boster Biological Technology Dystrophin Product and Services
Table 240. Boster Biological Technology Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 241. Boster Biological Technology Recent Developments/Updates
Table 242. Boster Biological Technology Competitive Strengths & Weaknesses
Table 243. Cloud-Clone Basic Information, Manufacturing Base and Competitors
Table 244. Cloud-Clone Major Business
Table 245. Cloud-Clone Dystrophin Product and Services
Table 246. Cloud-Clone Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 247. Cloud-Clone Recent Developments/Updates
Table 248. Cloud-Clone Competitive Strengths & Weaknesses
Table 249. FineTest Basic Information, Manufacturing Base and Competitors
Table 250. FineTest Major Business
Table 251. FineTest Dystrophin Product and Services
Table 252. FineTest Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 253. FineTest Recent Developments/Updates
Table 254. FineTest Competitive Strengths & Weaknesses
Table 255. CUSABIO Basic Information, Manufacturing Base and Competitors
Table 256. CUSABIO Major Business
Table 257. CUSABIO Dystrophin Product and Services
Table 258. CUSABIO Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 259. CUSABIO Recent Developments/Updates
Table 260. CUSABIO Competitive Strengths & Weaknesses
Table 261. Assay Genie Basic Information, Manufacturing Base and Competitors
Table 262. Assay Genie Major Business
Table 263. Assay Genie Dystrophin Product and Services
Table 264. Assay Genie Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 265. Assay Genie Recent Developments/Updates
Table 266. Assay Genie Competitive Strengths & Weaknesses
Table 267. Bioss Antibodies Basic Information, Manufacturing Base and Competitors
Table 268. Bioss Antibodies Major Business
Table 269. Bioss Antibodies Dystrophin Product and Services
Table 270. Bioss Antibodies Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 271. Bioss Antibodies Recent Developments/Updates
Table 272. Bioss Antibodies Competitive Strengths & Weaknesses
Table 273. XpressBio Basic Information, Manufacturing Base and Competitors
Table 274. XpressBio Major Business
Table 275. XpressBio Dystrophin Product and Services
Table 276. XpressBio Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 277. XpressBio Recent Developments/Updates
Table 278. XpressBio Competitive Strengths & Weaknesses
Table 279. BioGenex Basic Information, Manufacturing Base and Competitors
Table 280. BioGenex Major Business
Table 281. BioGenex Dystrophin Product and Services
Table 282. BioGenex Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 283. BioGenex Recent Developments/Updates
Table 284. BioGenex Competitive Strengths & Weaknesses
Table 285. United States Biological Basic Information, Manufacturing Base and Competitors
Table 286. United States Biological Major Business
Table 287. United States Biological Dystrophin Product and Services
Table 288. United States Biological Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 289. United States Biological Recent Developments/Updates
Table 290. United States Biological Competitive Strengths & Weaknesses
Table 291. Global Key Players of Dystrophin Upstream (Raw Materials)
Table 292. Global Dystrophin Typical Customers
Table 293. Dystrophin Typical Distributors
Table 1. World Dystrophin Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Dystrophin Production Value by Region (2021-2026) & (USD Million)
Table 3. World Dystrophin Production Value by Region (2027-2032) & (USD Million)
Table 4. World Dystrophin Production Value Market Share by Region (2021-2026)
Table 5. World Dystrophin Production Value Market Share by Region (2027-2032)
Table 6. World Dystrophin Production by Region (2021-2026) & (K Dose)
Table 7. World Dystrophin Production by Region (2027-2032) & (K Dose)
Table 8. World Dystrophin Production Market Share by Region (2021-2026)
Table 9. World Dystrophin Production Market Share by Region (2027-2032)
Table 10. World Dystrophin Average Price by Region (2021-2026) & (USD/Pcs)
Table 11. World Dystrophin Average Price by Region (2027-2032) & (USD/Pcs)
Table 12. Dystrophin Major Market Trends
Table 13. World Dystrophin Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Dystrophin Consumption by Region (2021-2026) & (K Dose)
Table 15. World Dystrophin Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Dystrophin Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Dystrophin Producers in 2025
Table 18. World Dystrophin Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Dystrophin Producers in 2025
Table 20. World Dystrophin Average Price by Manufacturer (2021-2026) & (USD/Pcs)
Table 21. Global Dystrophin Company Evaluation Quadrant
Table 22. World Dystrophin Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Dystrophin Production Site of Key Manufacturer
Table 24. Dystrophin Market: Company Product Type Footprint
Table 25. Dystrophin Market: Company Product Application Footprint
Table 26. Dystrophin Competitive Factors
Table 27. Dystrophin New Entrant and Capacity Expansion Plans
Table 28. Dystrophin Mergers & Acquisitions Activity
Table 29. United States VS China Dystrophin Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Dystrophin Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Dystrophin Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Dystrophin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Dystrophin Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Dystrophin Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Dystrophin Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Dystrophin Production Market Share (2021-2026)
Table 37. China Based Dystrophin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Dystrophin Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Dystrophin Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Dystrophin Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Dystrophin Production Market Share (2021-2026)
Table 42. Rest of World Based Dystrophin Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Dystrophin Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Dystrophin Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Dystrophin Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Dystrophin Production Market Share (2021-2026)
Table 47. World Dystrophin Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Dystrophin Production by Type (2021-2026) & (K Dose)
Table 49. World Dystrophin Production by Type (2027-2032) & (K Dose)
Table 50. World Dystrophin Production Value by Type (2021-2026) & (USD Million)
Table 51. World Dystrophin Production Value by Type (2027-2032) & (USD Million)
Table 52. World Dystrophin Average Price by Type (2021-2026) & (USD/Pcs)
Table 53. World Dystrophin Average Price by Type (2027-2032) & (USD/Pcs)
Table 54. World Dystrophin Production Value by Technology Route, (USD Million), 2021 & 2025 & 2032
Table 55. World Dystrophin Production by Technology Route (2021-2026) & (K Dose)
Table 56. World Dystrophin Production by Technology Route (2027-2032) & (K Dose)
Table 57. World Dystrophin Production Value by Technology Route (2021-2026) & (USD Million)
Table 58. World Dystrophin Production Value by Technology Route (2027-2032) & (USD Million)
Table 59. World Dystrophin Average Price by Technology Route (2021-2026) & (USD/Pcs)
Table 60. World Dystrophin Average Price by Technology Route (2027-2032) & (USD/Pcs)
Table 61. World Dystrophin Production Value by Product Format, (USD Million), 2021 & 2025 & 2032
Table 62. World Dystrophin Production by Product Format (2021-2026) & (K Dose)
Table 63. World Dystrophin Production by Product Format (2027-2032) & (K Dose)
Table 64. World Dystrophin Production Value by Product Format (2021-2026) & (USD Million)
Table 65. World Dystrophin Production Value by Product Format (2027-2032) & (USD Million)
Table 66. World Dystrophin Average Price by Product Format (2021-2026) & (USD/Pcs)
Table 67. World Dystrophin Average Price by Product Format (2027-2032) & (USD/Pcs)
Table 68. World Dystrophin Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Dystrophin Production by Application (2021-2026) & (K Dose)
Table 70. World Dystrophin Production by Application (2027-2032) & (K Dose)
Table 71. World Dystrophin Production Value by Application (2021-2026) & (USD Million)
Table 72. World Dystrophin Production Value by Application (2027-2032) & (USD Million)
Table 73. World Dystrophin Average Price by Application (2021-2026) & (USD/Pcs)
Table 74. World Dystrophin Average Price by Application (2027-2032) & (USD/Pcs)
Table 75. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
Table 76. Sarepta Therapeutics Major Business
Table 77. Sarepta Therapeutics Dystrophin Product and Services
Table 78. Sarepta Therapeutics Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Sarepta Therapeutics Recent Developments/Updates
Table 80. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 81. Roche Basic Information, Manufacturing Base and Competitors
Table 82. Roche Major Business
Table 83. Roche Dystrophin Product and Services
Table 84. Roche Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Roche Recent Developments/Updates
Table 86. Roche Competitive Strengths & Weaknesses
Table 87. Nippon Shinyaku Basic Information, Manufacturing Base and Competitors
Table 88. Nippon Shinyaku Major Business
Table 89. Nippon Shinyaku Dystrophin Product and Services
Table 90. Nippon Shinyaku Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Nippon Shinyaku Recent Developments/Updates
Table 92. Nippon Shinyaku Competitive Strengths & Weaknesses
Table 93. PTC Therapeutics Basic Information, Manufacturing Base and Competitors
Table 94. PTC Therapeutics Major Business
Table 95. PTC Therapeutics Dystrophin Product and Services
Table 96. PTC Therapeutics Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. PTC Therapeutics Recent Developments/Updates
Table 98. PTC Therapeutics Competitive Strengths & Weaknesses
Table 99. REGENXBIO Basic Information, Manufacturing Base and Competitors
Table 100. REGENXBIO Major Business
Table 101. REGENXBIO Dystrophin Product and Services
Table 102. REGENXBIO Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. REGENXBIO Recent Developments/Updates
Table 104. REGENXBIO Competitive Strengths & Weaknesses
Table 105. Solid Biosciences Basic Information, Manufacturing Base and Competitors
Table 106. Solid Biosciences Major Business
Table 107. Solid Biosciences Dystrophin Product and Services
Table 108. Solid Biosciences Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Solid Biosciences Recent Developments/Updates
Table 110. Solid Biosciences Competitive Strengths & Weaknesses
Table 111. Dyne Therapeutics Basic Information, Manufacturing Base and Competitors
Table 112. Dyne Therapeutics Major Business
Table 113. Dyne Therapeutics Dystrophin Product and Services
Table 114. Dyne Therapeutics Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Dyne Therapeutics Recent Developments/Updates
Table 116. Dyne Therapeutics Competitive Strengths & Weaknesses
Table 117. Avidity Biosciences Basic Information, Manufacturing Base and Competitors
Table 118. Avidity Biosciences Major Business
Table 119. Avidity Biosciences Dystrophin Product and Services
Table 120. Avidity Biosciences Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Avidity Biosciences Recent Developments/Updates
Table 122. Avidity Biosciences Competitive Strengths & Weaknesses
Table 123. Wave Life Sciences Basic Information, Manufacturing Base and Competitors
Table 124. Wave Life Sciences Major Business
Table 125. Wave Life Sciences Dystrophin Product and Services
Table 126. Wave Life Sciences Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Wave Life Sciences Recent Developments/Updates
Table 128. Wave Life Sciences Competitive Strengths & Weaknesses
Table 129. Entrada Therapeutics Basic Information, Manufacturing Base and Competitors
Table 130. Entrada Therapeutics Major Business
Table 131. Entrada Therapeutics Dystrophin Product and Services
Table 132. Entrada Therapeutics Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Entrada Therapeutics Recent Developments/Updates
Table 134. Entrada Therapeutics Competitive Strengths & Weaknesses
Table 135. Genethon Basic Information, Manufacturing Base and Competitors
Table 136. Genethon Major Business
Table 137. Genethon Dystrophin Product and Services
Table 138. Genethon Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Genethon Recent Developments/Updates
Table 140. Genethon Competitive Strengths & Weaknesses
Table 141. Code Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 142. Code Biotherapeutics Major Business
Table 143. Code Biotherapeutics Dystrophin Product and Services
Table 144. Code Biotherapeutics Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Code Biotherapeutics Recent Developments/Updates
Table 146. Code Biotherapeutics Competitive Strengths & Weaknesses
Table 147. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 148. Thermo Fisher Scientific Major Business
Table 149. Thermo Fisher Scientific Dystrophin Product and Services
Table 150. Thermo Fisher Scientific Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Thermo Fisher Scientific Recent Developments/Updates
Table 152. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 153. Abcam Basic Information, Manufacturing Base and Competitors
Table 154. Abcam Major Business
Table 155. Abcam Dystrophin Product and Services
Table 156. Abcam Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Abcam Recent Developments/Updates
Table 158. Abcam Competitive Strengths & Weaknesses
Table 159. Merck Basic Information, Manufacturing Base and Competitors
Table 160. Merck Major Business
Table 161. Merck Dystrophin Product and Services
Table 162. Merck Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Merck Recent Developments/Updates
Table 164. Merck Competitive Strengths & Weaknesses
Table 165. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 166. Bio-Techne Major Business
Table 167. Bio-Techne Dystrophin Product and Services
Table 168. Bio-Techne Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Bio-Techne Recent Developments/Updates
Table 170. Bio-Techne Competitive Strengths & Weaknesses
Table 171. Proteintech Basic Information, Manufacturing Base and Competitors
Table 172. Proteintech Major Business
Table 173. Proteintech Dystrophin Product and Services
Table 174. Proteintech Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Proteintech Recent Developments/Updates
Table 176. Proteintech Competitive Strengths & Weaknesses
Table 177. OriGene Basic Information, Manufacturing Base and Competitors
Table 178. OriGene Major Business
Table 179. OriGene Dystrophin Product and Services
Table 180. OriGene Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. OriGene Recent Developments/Updates
Table 182. OriGene Competitive Strengths & Weaknesses
Table 183. Cell Signaling Technology Basic Information, Manufacturing Base and Competitors
Table 184. Cell Signaling Technology Major Business
Table 185. Cell Signaling Technology Dystrophin Product and Services
Table 186. Cell Signaling Technology Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Cell Signaling Technology Recent Developments/Updates
Table 188. Cell Signaling Technology Competitive Strengths & Weaknesses
Table 189. Santa Cruz Biotechnology Basic Information, Manufacturing Base and Competitors
Table 190. Santa Cruz Biotechnology Major Business
Table 191. Santa Cruz Biotechnology Dystrophin Product and Services
Table 192. Santa Cruz Biotechnology Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Santa Cruz Biotechnology Recent Developments/Updates
Table 194. Santa Cruz Biotechnology Competitive Strengths & Weaknesses
Table 195. Atlas Antibodies Basic Information, Manufacturing Base and Competitors
Table 196. Atlas Antibodies Major Business
Table 197. Atlas Antibodies Dystrophin Product and Services
Table 198. Atlas Antibodies Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 199. Atlas Antibodies Recent Developments/Updates
Table 200. Atlas Antibodies Competitive Strengths & Weaknesses
Table 201. Leica Biosystems Basic Information, Manufacturing Base and Competitors
Table 202. Leica Biosystems Major Business
Table 203. Leica Biosystems Dystrophin Product and Services
Table 204. Leica Biosystems Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Leica Biosystems Recent Developments/Updates
Table 206. Leica Biosystems Competitive Strengths & Weaknesses
Table 207. Creative BioMart Basic Information, Manufacturing Base and Competitors
Table 208. Creative BioMart Major Business
Table 209. Creative BioMart Dystrophin Product and Services
Table 210. Creative BioMart Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 211. Creative BioMart Recent Developments/Updates
Table 212. Creative BioMart Competitive Strengths & Weaknesses
Table 213. MyBioSource Basic Information, Manufacturing Base and Competitors
Table 214. MyBioSource Major Business
Table 215. MyBioSource Dystrophin Product and Services
Table 216. MyBioSource Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 217. MyBioSource Recent Developments/Updates
Table 218. MyBioSource Competitive Strengths & Weaknesses
Table 219. NSJ Bioreagents Basic Information, Manufacturing Base and Competitors
Table 220. NSJ Bioreagents Major Business
Table 221. NSJ Bioreagents Dystrophin Product and Services
Table 222. NSJ Bioreagents Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 223. NSJ Bioreagents Recent Developments/Updates
Table 224. NSJ Bioreagents Competitive Strengths & Weaknesses
Table 225. Abbexa Basic Information, Manufacturing Base and Competitors
Table 226. Abbexa Major Business
Table 227. Abbexa Dystrophin Product and Services
Table 228. Abbexa Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 229. Abbexa Recent Developments/Updates
Table 230. Abbexa Competitive Strengths & Weaknesses
Table 231. Abnova Basic Information, Manufacturing Base and Competitors
Table 232. Abnova Major Business
Table 233. Abnova Dystrophin Product and Services
Table 234. Abnova Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 235. Abnova Recent Developments/Updates
Table 236. Abnova Competitive Strengths & Weaknesses
Table 237. Boster Biological Technology Basic Information, Manufacturing Base and Competitors
Table 238. Boster Biological Technology Major Business
Table 239. Boster Biological Technology Dystrophin Product and Services
Table 240. Boster Biological Technology Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 241. Boster Biological Technology Recent Developments/Updates
Table 242. Boster Biological Technology Competitive Strengths & Weaknesses
Table 243. Cloud-Clone Basic Information, Manufacturing Base and Competitors
Table 244. Cloud-Clone Major Business
Table 245. Cloud-Clone Dystrophin Product and Services
Table 246. Cloud-Clone Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 247. Cloud-Clone Recent Developments/Updates
Table 248. Cloud-Clone Competitive Strengths & Weaknesses
Table 249. FineTest Basic Information, Manufacturing Base and Competitors
Table 250. FineTest Major Business
Table 251. FineTest Dystrophin Product and Services
Table 252. FineTest Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 253. FineTest Recent Developments/Updates
Table 254. FineTest Competitive Strengths & Weaknesses
Table 255. CUSABIO Basic Information, Manufacturing Base and Competitors
Table 256. CUSABIO Major Business
Table 257. CUSABIO Dystrophin Product and Services
Table 258. CUSABIO Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 259. CUSABIO Recent Developments/Updates
Table 260. CUSABIO Competitive Strengths & Weaknesses
Table 261. Assay Genie Basic Information, Manufacturing Base and Competitors
Table 262. Assay Genie Major Business
Table 263. Assay Genie Dystrophin Product and Services
Table 264. Assay Genie Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 265. Assay Genie Recent Developments/Updates
Table 266. Assay Genie Competitive Strengths & Weaknesses
Table 267. Bioss Antibodies Basic Information, Manufacturing Base and Competitors
Table 268. Bioss Antibodies Major Business
Table 269. Bioss Antibodies Dystrophin Product and Services
Table 270. Bioss Antibodies Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 271. Bioss Antibodies Recent Developments/Updates
Table 272. Bioss Antibodies Competitive Strengths & Weaknesses
Table 273. XpressBio Basic Information, Manufacturing Base and Competitors
Table 274. XpressBio Major Business
Table 275. XpressBio Dystrophin Product and Services
Table 276. XpressBio Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 277. XpressBio Recent Developments/Updates
Table 278. XpressBio Competitive Strengths & Weaknesses
Table 279. BioGenex Basic Information, Manufacturing Base and Competitors
Table 280. BioGenex Major Business
Table 281. BioGenex Dystrophin Product and Services
Table 282. BioGenex Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 283. BioGenex Recent Developments/Updates
Table 284. BioGenex Competitive Strengths & Weaknesses
Table 285. United States Biological Basic Information, Manufacturing Base and Competitors
Table 286. United States Biological Major Business
Table 287. United States Biological Dystrophin Product and Services
Table 288. United States Biological Dystrophin Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 289. United States Biological Recent Developments/Updates
Table 290. United States Biological Competitive Strengths & Weaknesses
Table 291. Global Key Players of Dystrophin Upstream (Raw Materials)
Table 292. Global Dystrophin Typical Customers
Table 293. Dystrophin Typical Distributors
LIST OF FIGURES
Figure 1. Dystrophin Picture
Figure 2. World Dystrophin Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Dystrophin Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Dystrophin Production (2021-2032) & (K Dose)
Figure 5. World Dystrophin Average Price (2021-2032) & (USD/Pcs)
Figure 6. World Dystrophin Production Value Market Share by Region (2021-2032)
Figure 7. World Dystrophin Production Market Share by Region (2021-2032)
Figure 8. North America Dystrophin Production (2021-2032) & (K Dose)
Figure 9. Europe Dystrophin Production (2021-2032) & (K Dose)
Figure 10. China Dystrophin Production (2021-2032) & (K Dose)
Figure 11. Japan Dystrophin Production (2021-2032) & (K Dose)
Figure 12. Dystrophin Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Dystrophin Consumption (2021-2032) & (K Dose)
Figure 15. World Dystrophin Consumption Market Share by Region (2021-2032)
Figure 16. United States Dystrophin Consumption (2021-2032) & (K Dose)
Figure 17. China Dystrophin Consumption (2021-2032) & (K Dose)
Figure 18. Europe Dystrophin Consumption (2021-2032) & (K Dose)
Figure 19. Japan Dystrophin Consumption (2021-2032) & (K Dose)
Figure 20. South Korea Dystrophin Consumption (2021-2032) & (K Dose)
Figure 21. ASEAN Dystrophin Consumption (2021-2032) & (K Dose)
Figure 22. India Dystrophin Consumption (2021-2032) & (K Dose)
Figure 23. Producer Shipments of Dystrophin by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Dystrophin Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Dystrophin Markets in 2025
Figure 26. United States VS China: Dystrophin Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Dystrophin Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Dystrophin Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Dystrophin Production Market Share 2025
Figure 30. China Based Manufacturers Dystrophin Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Dystrophin Production Market Share 2025
Figure 32. World Dystrophin Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Dystrophin Production Value Market Share by Type in 2025
Figure 34. DS-5141
Figure 35. Biostrophin
Figure 36. BMBD-001
Figure 37. NS-065
Figure 38. Others
Figure 39. World Dystrophin Production Market Share by Type (2021-2032)
Figure 40. World Dystrophin Production Value Market Share by Type (2021-2032)
Figure 41. World Dystrophin Average Price by Type (2021-2032) & (USD/Pcs)
Figure 42. World Dystrophin Production Value by Technology Route, (USD Million), 2021 & 2025 & 2032
Figure 43. World Dystrophin Production Value Market Share by Technology Route in 2025
Figure 44. Exon-skipping Therapy
Figure 45. Gene Therapy
Figure 46. Stop-codon Readthrough Therapy
Figure 47. Others
Figure 48. World Dystrophin Production Market Share by Technology Route (2021-2032)
Figure 49. World Dystrophin Production Value Market Share by Technology Route (2021-2032)
Figure 50. World Dystrophin Average Price by Technology Route (2021-2032) & (USD/Pcs)
Figure 51. World Dystrophin Production Value by Product Format, (USD Million), 2021 & 2025 & 2032
Figure 52. World Dystrophin Production Value Market Share by Product Format in 2025
Figure 53. Therapeutic Drugs and Vectors
Figure 54. Antibodies and Assay Kits
Figure 55. Recombinant Proteins and Protein Fragments
Figure 56. Others
Figure 57. World Dystrophin Production Market Share by Product Format (2021-2032)
Figure 58. World Dystrophin Production Value Market Share by Product Format (2021-2032)
Figure 59. World Dystrophin Average Price by Product Format (2021-2032) & (USD/Pcs)
Figure 60. World Dystrophin Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 61. World Dystrophin Production Value Market Share by Application in 2025
Figure 62. Genetic Disorders
Figure 63. Musculoskeletal Disorders
Figure 64. Others
Figure 65. World Dystrophin Production Market Share by Application (2021-2032)
Figure 66. World Dystrophin Production Value Market Share by Application (2021-2032)
Figure 67. World Dystrophin Average Price by Application (2021-2032) & (USD/Pcs)
Figure 68. Dystrophin Industry Chain
Figure 69. Dystrophin Procurement Model
Figure 70. Dystrophin Sales Model
Figure 71. Dystrophin Sales Channels, Direct Sales, and Distribution
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Dystrophin Picture
Figure 2. World Dystrophin Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Dystrophin Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Dystrophin Production (2021-2032) & (K Dose)
Figure 5. World Dystrophin Average Price (2021-2032) & (USD/Pcs)
Figure 6. World Dystrophin Production Value Market Share by Region (2021-2032)
Figure 7. World Dystrophin Production Market Share by Region (2021-2032)
Figure 8. North America Dystrophin Production (2021-2032) & (K Dose)
Figure 9. Europe Dystrophin Production (2021-2032) & (K Dose)
Figure 10. China Dystrophin Production (2021-2032) & (K Dose)
Figure 11. Japan Dystrophin Production (2021-2032) & (K Dose)
Figure 12. Dystrophin Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Dystrophin Consumption (2021-2032) & (K Dose)
Figure 15. World Dystrophin Consumption Market Share by Region (2021-2032)
Figure 16. United States Dystrophin Consumption (2021-2032) & (K Dose)
Figure 17. China Dystrophin Consumption (2021-2032) & (K Dose)
Figure 18. Europe Dystrophin Consumption (2021-2032) & (K Dose)
Figure 19. Japan Dystrophin Consumption (2021-2032) & (K Dose)
Figure 20. South Korea Dystrophin Consumption (2021-2032) & (K Dose)
Figure 21. ASEAN Dystrophin Consumption (2021-2032) & (K Dose)
Figure 22. India Dystrophin Consumption (2021-2032) & (K Dose)
Figure 23. Producer Shipments of Dystrophin by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Dystrophin Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Dystrophin Markets in 2025
Figure 26. United States VS China: Dystrophin Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Dystrophin Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Dystrophin Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Dystrophin Production Market Share 2025
Figure 30. China Based Manufacturers Dystrophin Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Dystrophin Production Market Share 2025
Figure 32. World Dystrophin Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Dystrophin Production Value Market Share by Type in 2025
Figure 34. DS-5141
Figure 35. Biostrophin
Figure 36. BMBD-001
Figure 37. NS-065
Figure 38. Others
Figure 39. World Dystrophin Production Market Share by Type (2021-2032)
Figure 40. World Dystrophin Production Value Market Share by Type (2021-2032)
Figure 41. World Dystrophin Average Price by Type (2021-2032) & (USD/Pcs)
Figure 42. World Dystrophin Production Value by Technology Route, (USD Million), 2021 & 2025 & 2032
Figure 43. World Dystrophin Production Value Market Share by Technology Route in 2025
Figure 44. Exon-skipping Therapy
Figure 45. Gene Therapy
Figure 46. Stop-codon Readthrough Therapy
Figure 47. Others
Figure 48. World Dystrophin Production Market Share by Technology Route (2021-2032)
Figure 49. World Dystrophin Production Value Market Share by Technology Route (2021-2032)
Figure 50. World Dystrophin Average Price by Technology Route (2021-2032) & (USD/Pcs)
Figure 51. World Dystrophin Production Value by Product Format, (USD Million), 2021 & 2025 & 2032
Figure 52. World Dystrophin Production Value Market Share by Product Format in 2025
Figure 53. Therapeutic Drugs and Vectors
Figure 54. Antibodies and Assay Kits
Figure 55. Recombinant Proteins and Protein Fragments
Figure 56. Others
Figure 57. World Dystrophin Production Market Share by Product Format (2021-2032)
Figure 58. World Dystrophin Production Value Market Share by Product Format (2021-2032)
Figure 59. World Dystrophin Average Price by Product Format (2021-2032) & (USD/Pcs)
Figure 60. World Dystrophin Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 61. World Dystrophin Production Value Market Share by Application in 2025
Figure 62. Genetic Disorders
Figure 63. Musculoskeletal Disorders
Figure 64. Others
Figure 65. World Dystrophin Production Market Share by Application (2021-2032)
Figure 66. World Dystrophin Production Value Market Share by Application (2021-2032)
Figure 67. World Dystrophin Average Price by Application (2021-2032) & (USD/Pcs)
Figure 68. Dystrophin Industry Chain
Figure 69. Dystrophin Procurement Model
Figure 70. Dystrophin Sales Model
Figure 71. Dystrophin Sales Channels, Direct Sales, and Distribution
Figure 72. Methodology
Figure 73. Research Process and Data Source
